seems the executive teams for Biogen and Zosano have been meeting a lot as of late..
backfilling that empty pipeline.
apparently a quarter of funds earmarked for the 1 billion stock buyback will actually go towards acquiring this migraine therapy in a cash and stock deal.
Being scooped up now.
Deal to be announced in next 2 weeks.
Nothing novel, but the micro-needle stamp costs 10 a pop to make, has already gotten FDA greenlight (new commish and investor on the board went to prep school together) and will be sold for at least a couple hundred per dose.
Low hanging fruit, but easy profit. $$
Marketing to start Jan next year.
You’re welcome
backfilling that empty pipeline.
apparently a quarter of funds earmarked for the 1 billion stock buyback will actually go towards acquiring this migraine therapy in a cash and stock deal.
Being scooped up now.
Deal to be announced in next 2 weeks.
Nothing novel, but the micro-needle stamp costs 10 a pop to make, has already gotten FDA greenlight (new commish and investor on the board went to prep school together) and will be sold for at least a couple hundred per dose.
Low hanging fruit, but easy profit. $$
Marketing to start Jan next year.
You’re welcome